Cancers, Vol. 16, Pages 1188: Investigating the Efficacy of EGFR-TKIs and Anti-VEGFR Combination in Advanced Non-Small Cell Lung Cancer: A Meta-Analysis
Conclusions: Our meta-analysis indicated EGFR-TKIs with anti-VEGFR in combination not only improved overall PFS but also showed similar results to a first line and first-generation agent compared to EGFR-TKI alone.
Source: Cancers - Category: Cancer & Oncology Authors: Prashant Sakharkar Sonali Kurup Subrata Deb Kaitlin Assaad Dayna Gesinski Erysa J. Gayle Tags: Systematic Review Source Type: research
More News: Avastin | Cancer | Cancer & Oncology | Databases & Libraries | Lung Cancer | Non-Small Cell Lung Cancer | Study